Director Mineo Chrysa purchased Cidara Therapeutics ($CDTX) shares on the open market twice in the last year, for a total of nearly $74,000. The most recent buy occurred on June 3, 2025. These insider purchases rank 2,667th out of 4,983 individuals in our database, well below the average buy amount of $1.46 million across 3.29 transactions per buyer. Mineo Chrysa reported no open market sales in the past year.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Stock Option (right to buy) | 11100 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.04% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Stock Option (right to buy) | 875 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.00% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Stock Option (right to buy) | 1400 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.00% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Stock Option (right to buy) | 2125 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.01% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Stock Option (right to buy) | 2125 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.01% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Stock Option (right to buy) | 19000 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.06% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Common Stock | 3320 | $221.50 | 0.0000 | 31,439,371 | 100.00% | 0.01% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Stock Option (right to buy) | 1000 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.00% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Stock Option (right to buy) | 550 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.00% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Stock Option (right to buy) | 550 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.00% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | D | Stock Option (right to buy) | 875 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.00% |
| June 18, 2025 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | A | Stock Option (right to buy) | 11100 | $0.00 | 11,100.0000 | 10,953,490 | 9999.99% | 0.10% |
| June 2, 2025 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | P | Common Stock | 2270 | $21.71 | 2,270.0000 | 10,953,490 | 9999.99% | 0.02% |
| June 3, 2025 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | P | Common Stock | 1050 | $23.44 | 3,320.0000 | 10,953,490 | 46.26% | 0.01% |
| Dec. 17, 2024 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 0 | 9999.99% | 0.00% |
| July 18, 2024 | Cidara Therapeutics, Inc. | $CDTX | Mineo Chrysa | Director | A | Stock Option (right to buy) | 2125 | $0.00 | 2,125.0000 | 0 | 9999.99% | 0.00% |